India’s pharma industry is entering AI execution phase: What comes after the pilot?
Shammi Thakur, Research Director, Vyansa Intelligence highlights that the next phase of AI adoption in Indian pharma will depend…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Guest Blogs
A missed opportunity for GS1 to explain why India’s barcoding programme is not a danger to society
A recent essay in Express Pharma by Mr. S. Swaminathan, CEO of GS1 India, extolled the benefits of the QR barcoding programme and…
India’s biotech self-reliance moment
For much of the past two decades, global biotech leadership has clustered around a handful of hubs, each anchored by patient…
How pharma is charting a greener path to growth
The conversation around environmental sustainability in the pharma industry is now expanding beyond the traditional boundaries of…
GST on vaccines: Time for clarity, not litigation
Santosh Dalvi and Saurabh Jain highlight the need for clarity on GST classification of vaccines to reduce interpretational…
Geopolitics and pharma packaging: Building greater security across the supply chain
India's pharma strength and its new operating reality
The Indian pharmaceutical industry has evolved into one of the most…
Unclogging India’s innovation pipeline
Innovation is often measured through rankings, patents and startup success stories. While these are important indicators, they…
From capacity to capability: Five proofs for India’s pharma future
India’s ability to supply affordable medicines at scale is strategic infrastructure for patients, health systems and global supply…
Redefining clinical research: how AI and digital innovation are putting patients at the center
As per a recent research, around 80 percent of clinical trials fail to meet their original enrollment timelines. Such delays are…
An effective methodology for diabetes prediction in the case of class imbalance
Dr Vincent Hooper highlights how a machine learning methodology can improve diabetes prediction in clinical datasets affected by…
Key challenges in regulating pharma marketing in India
Dr Suresh R. Saravdekar highlights the need for statutory regulation, mandatory disclosure and stronger oversight of…
Rx-to-OTC Is only the beginning: Why some brands grow and others don’t
Vilas Hegade explains why commercial execution determines the success of Rx-to-OTC brands
Why clinical governance and doctor-led protocols are becoming increasingly important in aesthetic…
Aesthetic medicine is no longer a boutique corner of healthcare. The International Society of Aesthetic Plastic Surgery counted…
The convergence of dermatology, wellness, and longevity medicine
Dermatology has always occupied an unusual position in medicine — visible enough to attract cultural attention, complex enough to…
Bridging generics and specialty: A roadmap to complex molecule innovation
We keep telling ourselves the same story: India is the pharmacy of the world, and now it is graduating to specialty. I have sat…
End of OTC cough syrups: Should more medicines move behind the prescription wall?
Why the regulation matters
This recent move to limit the sale of some cough syrups over-the-counter (OTC) is an essential…
India’s online pharmacy boom and the perils of unregulated medicine
Online shopping has trained us to value one thing above all others: visibility. Yet what empowers a consumer comparing prices…
How AI is redefining India’s pharmaceutical export edge
India's pharmaceutical industry has gained an international reputation due to its large-scale production, advanced scientific…
Redefining pharma warehousing: The shift from storage facilities to compliance-driven supply chain…
Pharmaceutical warehousing has evolved significantly from a backend storage function to a critical component of regulated supply…
Biopharma 4.0: How Ireland and India can shape the next era of smart manufacturing
The global biopharma sector is entering a moment where the old rules of competitiveness are being rewritten. For decades, market…